0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Modifying Agents Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-37B18190
Home | Market Reports | Science| Biological Sciences
Global RNA Modifying Agents Market Research Report 2024
BUY CHAPTERS

Global RNA Modifying Agents Market Research Report 2024

Code: QYRE-Auto-37B18190
Report
September 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

RNA Modifying Agents Market

RNA modifications refer to various chemical modifications added to RNA molecules, which affect the function, stability and expression of RNA. RNA modifications play an important role in the regulation of gene expression, RNA processing and translation. There are many types of RNA modifications, and the content and function of different types of RNA modifications vary greatly. Among them, methylation modification is one of the main forms of RNA modification. This report mainly studies RNA methylation modification.
The global RNA Modifying Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for RNA Modifying Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Modifying Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of RNA Modifying Agents include Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, abcam, ABclonal, MyBioSource, Beyotime, Hologic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for RNA Modifying Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Modifying Agents.
The RNA Modifying Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global RNA Modifying Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Modifying Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of RNA Modifying Agents Market Report

Report Metric Details
Report Name RNA Modifying Agents Market
Segment by Type
  • N6-Methyladenosine (m6A) Antibody
  • 5-Methylcytosine (5-mC) Antibody
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, abcam, ABclonal, MyBioSource, Beyotime, Hologic, Synaptic Systems, Novus Biologicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of RNA Modifying Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of RNA Modifying Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Modifying Agents Market report?

Ans: The main players in the RNA Modifying Agents Market are Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, abcam, ABclonal, MyBioSource, Beyotime, Hologic, Synaptic Systems, Novus Biologicals

What are the Application segmentation covered in the RNA Modifying Agents Market report?

Ans: The Applications covered in the RNA Modifying Agents Market report are Gene Therapy, Cancer Research, Drug Development, Other

What are the Type segmentation covered in the RNA Modifying Agents Market report?

Ans: The Types covered in the RNA Modifying Agents Market report are N6-Methyladenosine (m6A) Antibody, 5-Methylcytosine (5-mC) Antibody, Others

Recommended Reports

RNA Sequencing Markets

Gene Therapy & Modification

RNA/Molecular Reagents

1 RNA Modifying Agents Market Overview
1.1 Product Definition
1.2 RNA Modifying Agents by Type
1.2.1 Global RNA Modifying Agents Market Value Comparison by Type (2024-2030)
1.2.2 N6-Methyladenosine (m6A) Antibody
1.2.3 5-Methylcytosine (5-mC) Antibody
1.2.4 Others
1.3 RNA Modifying Agents by Application
1.3.1 Global RNA Modifying Agents Market Value by Application (2024-2030)
1.3.2 Gene Therapy
1.3.3 Cancer Research
1.3.4 Drug Development
1.3.5 Other
1.4 Global RNA Modifying Agents Market Size Estimates and Forecasts
1.4.1 Global RNA Modifying Agents Revenue 2019-2030
1.4.2 Global RNA Modifying Agents Sales 2019-2030
1.4.3 Global RNA Modifying Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 RNA Modifying Agents Market Competition by Manufacturers
2.1 Global RNA Modifying Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global RNA Modifying Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global RNA Modifying Agents Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of RNA Modifying Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of RNA Modifying Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of RNA Modifying Agents, Product Type & Application
2.7 Global Key Manufacturers of RNA Modifying Agents, Date of Enter into This Industry
2.8 Global RNA Modifying Agents Market Competitive Situation and Trends
2.8.1 Global RNA Modifying Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest RNA Modifying Agents Players Market Share by Revenue
2.8.3 Global RNA Modifying Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global RNA Modifying Agents Market Scenario by Region
3.1 Global RNA Modifying Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global RNA Modifying Agents Sales by Region: 2019-2030
3.2.1 Global RNA Modifying Agents Sales by Region: 2019-2024
3.2.2 Global RNA Modifying Agents Sales by Region: 2025-2030
3.3 Global RNA Modifying Agents Revenue by Region: 2019-2030
3.3.1 Global RNA Modifying Agents Revenue by Region: 2019-2024
3.3.2 Global RNA Modifying Agents Revenue by Region: 2025-2030
3.4 North America RNA Modifying Agents Market Facts & Figures by Country
3.4.1 North America RNA Modifying Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America RNA Modifying Agents Sales by Country (2019-2030)
3.4.3 North America RNA Modifying Agents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe RNA Modifying Agents Market Facts & Figures by Country
3.5.1 Europe RNA Modifying Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe RNA Modifying Agents Sales by Country (2019-2030)
3.5.3 Europe RNA Modifying Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Modifying Agents Market Facts & Figures by Region
3.6.1 Asia Pacific RNA Modifying Agents Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific RNA Modifying Agents Sales by Region (2019-2030)
3.6.3 Asia Pacific RNA Modifying Agents Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America RNA Modifying Agents Market Facts & Figures by Country
3.7.1 Latin America RNA Modifying Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America RNA Modifying Agents Sales by Country (2019-2030)
3.7.3 Latin America RNA Modifying Agents Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa RNA Modifying Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Modifying Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa RNA Modifying Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa RNA Modifying Agents Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global RNA Modifying Agents Sales by Type (2019-2030)
4.1.1 Global RNA Modifying Agents Sales by Type (2019-2024)
4.1.2 Global RNA Modifying Agents Sales by Type (2025-2030)
4.1.3 Global RNA Modifying Agents Sales Market Share by Type (2019-2030)
4.2 Global RNA Modifying Agents Revenue by Type (2019-2030)
4.2.1 Global RNA Modifying Agents Revenue by Type (2019-2024)
4.2.2 Global RNA Modifying Agents Revenue by Type (2025-2030)
4.2.3 Global RNA Modifying Agents Revenue Market Share by Type (2019-2030)
4.3 Global RNA Modifying Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global RNA Modifying Agents Sales by Application (2019-2030)
5.1.1 Global RNA Modifying Agents Sales by Application (2019-2024)
5.1.2 Global RNA Modifying Agents Sales by Application (2025-2030)
5.1.3 Global RNA Modifying Agents Sales Market Share by Application (2019-2030)
5.2 Global RNA Modifying Agents Revenue by Application (2019-2030)
5.2.1 Global RNA Modifying Agents Revenue by Application (2019-2024)
5.2.2 Global RNA Modifying Agents Revenue by Application (2025-2030)
5.2.3 Global RNA Modifying Agents Revenue Market Share by Application (2019-2030)
5.3 Global RNA Modifying Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Active Motif
6.1.1 Active Motif Company Information
6.1.2 Active Motif Description and Business Overview
6.1.3 Active Motif RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Active Motif RNA Modifying Agents Product Portfolio
6.1.5 Active Motif Recent Developments/Updates
6.2 Epigentek
6.2.1 Epigentek Company Information
6.2.2 Epigentek Description and Business Overview
6.2.3 Epigentek RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Epigentek RNA Modifying Agents Product Portfolio
6.2.5 Epigentek Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Scientific RNA Modifying Agents Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck RNA Modifying Agents Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Gene Link
6.5.1 Gene Link Company Information
6.5.2 Gene Link Description and Business Overview
6.5.3 Gene Link RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gene Link RNA Modifying Agents Product Portfolio
6.5.5 Gene Link Recent Developments/Updates
6.6 abcam
6.6.1 abcam Company Information
6.6.2 abcam Description and Business Overview
6.6.3 abcam RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 abcam RNA Modifying Agents Product Portfolio
6.6.5 abcam Recent Developments/Updates
6.7 ABclonal
6.7.1 ABclonal Company Information
6.7.2 ABclonal Description and Business Overview
6.7.3 ABclonal RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.7.4 ABclonal RNA Modifying Agents Product Portfolio
6.7.5 ABclonal Recent Developments/Updates
6.8 MyBioSource
6.8.1 MyBioSource Company Information
6.8.2 MyBioSource Description and Business Overview
6.8.3 MyBioSource RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MyBioSource RNA Modifying Agents Product Portfolio
6.8.5 MyBioSource Recent Developments/Updates
6.9 Beyotime
6.9.1 Beyotime Company Information
6.9.2 Beyotime Description and Business Overview
6.9.3 Beyotime RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beyotime RNA Modifying Agents Product Portfolio
6.9.5 Beyotime Recent Developments/Updates
6.10 Hologic
6.10.1 Hologic Company Information
6.10.2 Hologic Description and Business Overview
6.10.3 Hologic RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hologic RNA Modifying Agents Product Portfolio
6.10.5 Hologic Recent Developments/Updates
6.11 Synaptic Systems
6.11.1 Synaptic Systems Company Information
6.11.2 Synaptic Systems Description and Business Overview
6.11.3 Synaptic Systems RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Synaptic Systems RNA Modifying Agents Product Portfolio
6.11.5 Synaptic Systems Recent Developments/Updates
6.12 Novus Biologicals
6.12.1 Novus Biologicals Company Information
6.12.2 Novus Biologicals Description and Business Overview
6.12.3 Novus Biologicals RNA Modifying Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novus Biologicals RNA Modifying Agents Product Portfolio
6.12.5 Novus Biologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Modifying Agents Industry Chain Analysis
7.2 RNA Modifying Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Modifying Agents Production Mode & Process
7.4 RNA Modifying Agents Sales and Marketing
7.4.1 RNA Modifying Agents Sales Channels
7.4.2 RNA Modifying Agents Distributors
7.5 RNA Modifying Agents Customers
8 RNA Modifying Agents Market Dynamics
8.1 RNA Modifying Agents Industry Trends
8.2 RNA Modifying Agents Market Drivers
8.3 RNA Modifying Agents Market Challenges
8.4 RNA Modifying Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global RNA Modifying Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global RNA Modifying Agents Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global RNA Modifying Agents Market Competitive Situation by Manufacturers in 2023
 Table 4. Global RNA Modifying Agents Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global RNA Modifying Agents Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global RNA Modifying Agents Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global RNA Modifying Agents Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market RNA Modifying Agents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of RNA Modifying Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of RNA Modifying Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of RNA Modifying Agents, Product Type & Application
 Table 12. Global Key Manufacturers of RNA Modifying Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global RNA Modifying Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Modifying Agents as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global RNA Modifying Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global RNA Modifying Agents Sales by Region (2019-2024) & (K Units)
 Table 18. Global RNA Modifying Agents Sales Market Share by Region (2019-2024)
 Table 19. Global RNA Modifying Agents Sales by Region (2025-2030) & (K Units)
 Table 20. Global RNA Modifying Agents Sales Market Share by Region (2025-2030)
 Table 21. Global RNA Modifying Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global RNA Modifying Agents Revenue Market Share by Region (2019-2024)
 Table 23. Global RNA Modifying Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global RNA Modifying Agents Revenue Market Share by Region (2025-2030)
 Table 25. North America RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America RNA Modifying Agents Sales by Country (2019-2024) & (K Units)
 Table 27. North America RNA Modifying Agents Sales by Country (2025-2030) & (K Units)
 Table 28. North America RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America RNA Modifying Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe RNA Modifying Agents Sales by Country (2019-2024) & (K Units)
 Table 32. Europe RNA Modifying Agents Sales by Country (2025-2030) & (K Units)
 Table 33. Europe RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe RNA Modifying Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific RNA Modifying Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific RNA Modifying Agents Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific RNA Modifying Agents Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific RNA Modifying Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific RNA Modifying Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America RNA Modifying Agents Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America RNA Modifying Agents Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America RNA Modifying Agents Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa RNA Modifying Agents Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa RNA Modifying Agents Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa RNA Modifying Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global RNA Modifying Agents Sales (K Units) by Type (2019-2024)
 Table 51. Global RNA Modifying Agents Sales (K Units) by Type (2025-2030)
 Table 52. Global RNA Modifying Agents Sales Market Share by Type (2019-2024)
 Table 53. Global RNA Modifying Agents Sales Market Share by Type (2025-2030)
 Table 54. Global RNA Modifying Agents Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global RNA Modifying Agents Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global RNA Modifying Agents Revenue Market Share by Type (2019-2024)
 Table 57. Global RNA Modifying Agents Revenue Market Share by Type (2025-2030)
 Table 58. Global RNA Modifying Agents Price (US$/Unit) by Type (2019-2024)
 Table 59. Global RNA Modifying Agents Price (US$/Unit) by Type (2025-2030)
 Table 60. Global RNA Modifying Agents Sales (K Units) by Application (2019-2024)
 Table 61. Global RNA Modifying Agents Sales (K Units) by Application (2025-2030)
 Table 62. Global RNA Modifying Agents Sales Market Share by Application (2019-2024)
 Table 63. Global RNA Modifying Agents Sales Market Share by Application (2025-2030)
 Table 64. Global RNA Modifying Agents Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global RNA Modifying Agents Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global RNA Modifying Agents Revenue Market Share by Application (2019-2024)
 Table 67. Global RNA Modifying Agents Revenue Market Share by Application (2025-2030)
 Table 68. Global RNA Modifying Agents Price (US$/Unit) by Application (2019-2024)
 Table 69. Global RNA Modifying Agents Price (US$/Unit) by Application (2025-2030)
 Table 70. Active Motif Company Information
 Table 71. Active Motif Description and Business Overview
 Table 72. Active Motif RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Active Motif RNA Modifying Agents Product
 Table 74. Active Motif Recent Developments/Updates
 Table 75. Epigentek Company Information
 Table 76. Epigentek Description and Business Overview
 Table 77. Epigentek RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Epigentek RNA Modifying Agents Product
 Table 79. Epigentek Recent Developments/Updates
 Table 80. Thermo Fisher Scientific Company Information
 Table 81. Thermo Fisher Scientific Description and Business Overview
 Table 82. Thermo Fisher Scientific RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Thermo Fisher Scientific RNA Modifying Agents Product
 Table 84. Thermo Fisher Scientific Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Merck RNA Modifying Agents Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Gene Link Company Information
 Table 91. Gene Link Description and Business Overview
 Table 92. Gene Link RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Gene Link RNA Modifying Agents Product
 Table 94. Gene Link Recent Developments/Updates
 Table 95. abcam Company Information
 Table 96. abcam Description and Business Overview
 Table 97. abcam RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. abcam RNA Modifying Agents Product
 Table 99. abcam Recent Developments/Updates
 Table 100. ABclonal Company Information
 Table 101. ABclonal Description and Business Overview
 Table 102. ABclonal RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. ABclonal RNA Modifying Agents Product
 Table 104. ABclonal Recent Developments/Updates
 Table 105. MyBioSource Company Information
 Table 106. MyBioSource Description and Business Overview
 Table 107. MyBioSource RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. MyBioSource RNA Modifying Agents Product
 Table 109. MyBioSource Recent Developments/Updates
 Table 110. Beyotime Company Information
 Table 111. Beyotime Description and Business Overview
 Table 112. Beyotime RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Beyotime RNA Modifying Agents Product
 Table 114. Beyotime Recent Developments/Updates
 Table 115. Hologic Company Information
 Table 116. Hologic Description and Business Overview
 Table 117. Hologic RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Hologic RNA Modifying Agents Product
 Table 119. Hologic Recent Developments/Updates
 Table 120. Synaptic Systems Company Information
 Table 121. Synaptic Systems Description and Business Overview
 Table 122. Synaptic Systems RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Synaptic Systems RNA Modifying Agents Product
 Table 124. Synaptic Systems Recent Developments/Updates
 Table 125. Novus Biologicals Company Information
 Table 126. Novus Biologicals Description and Business Overview
 Table 127. Novus Biologicals RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Novus Biologicals RNA Modifying Agents Product
 Table 129. Novus Biologicals Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. RNA Modifying Agents Distributors List
 Table 133. RNA Modifying Agents Customers List
 Table 134. RNA Modifying Agents Market Trends
 Table 135. RNA Modifying Agents Market Drivers
 Table 136. RNA Modifying Agents Market Challenges
 Table 137. RNA Modifying Agents Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of RNA Modifying Agents
 Figure 2. Global RNA Modifying Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global RNA Modifying Agents Market Share by Type: 2023 & 2030
 Figure 4. N6-Methyladenosine (m6A) Antibody Product Picture
 Figure 5. 5-Methylcytosine (5-mC) Antibody Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global RNA Modifying Agents Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global RNA Modifying Agents Market Share by Application: 2023 & 2030
 Figure 9. Gene Therapy
 Figure 10. Cancer Research
 Figure 11. Drug Development
 Figure 12. Other
 Figure 13. Global RNA Modifying Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global RNA Modifying Agents Market Size (2019-2030) & (US$ Million)
 Figure 15. Global RNA Modifying Agents Sales (2019-2030) & (K Units)
 Figure 16. Global RNA Modifying Agents Average Price (US$/Unit) & (2019-2030)
 Figure 17. RNA Modifying Agents Report Years Considered
 Figure 18. RNA Modifying Agents Sales Share by Manufacturers in 2023
 Figure 19. Global RNA Modifying Agents Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest RNA Modifying Agents Players: Market Share by Revenue in RNA Modifying Agents in 2023
 Figure 21. RNA Modifying Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global RNA Modifying Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America RNA Modifying Agents Sales Market Share by Country (2019-2030)
 Figure 24. North America RNA Modifying Agents Revenue Market Share by Country (2019-2030)
 Figure 25. United States RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe RNA Modifying Agents Sales Market Share by Country (2019-2030)
 Figure 28. Europe RNA Modifying Agents Revenue Market Share by Country (2019-2030)
 Figure 29. Germany RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific RNA Modifying Agents Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific RNA Modifying Agents Revenue Market Share by Region (2019-2030)
 Figure 36. China RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America RNA Modifying Agents Sales Market Share by Country (2019-2030)
 Figure 44. Mexico RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa RNA Modifying Agents Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa RNA Modifying Agents Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE RNA Modifying Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of RNA Modifying Agents by Type (2019-2030)
 Figure 54. Global Revenue Market Share of RNA Modifying Agents by Type (2019-2030)
 Figure 55. Global RNA Modifying Agents Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of RNA Modifying Agents by Application (2019-2030)
 Figure 57. Global Revenue Market Share of RNA Modifying Agents by Application (2019-2030)
 Figure 58. Global RNA Modifying Agents Price (US$/Unit) by Application (2019-2030)
 Figure 59. RNA Modifying Agents Value Chain
 Figure 60. RNA Modifying Agents Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart